Clinical Outcomes of Yamane Intrascleral Haptic Fixation: My First 150 Cases | ASCRS
Presentation
Clinical Outcomes of Yamane Intrascleral Haptic Fixation: My First 150 Cases
May 2020
Meeting: 2020 Virtual Annual Meeting
Session: SPS-113 Cataract - Challenging Cases
Authors: Amal M. Alwreikat, MD, Naveen Rao MD, Amer Alwreikat MD, Mohammed AL-yarabi MD, Ahmed AL-Rawi MD, Hesham Al-Rawashdeh MD, Mansoor AL Yarbi MSc
This content is only available for ASCRS Members

This content from the 2020 ASCRS Virtual Annual Meeting is only available to ASCRS members. To log in, click the teal "Login" button in the upper right-hand corner of this page.

Purpose
To present visual outcomes and complications of Yamane Intrascleral Haptic Fixation.

Methods
150 eyes of patients who underwent Yamane ISHF by one Cornea/anterior segment surgeon. Indications for surgery were aphakia, dislocated IOL, or subluxated crystalline lens. Data was collected for eyes with minimum 12 months follow up.

Results
Mean BCVA improved from 0.51 pre-operatively to 0.22, 0.21, 0.18, 0.17 logMAR units on day one, 3, 6 and 12 months, (p<0.001 for all time points). Complications included ocular hypertension 5 eyes (3.3%), vitreous hemorrhage in 3.3%, CME in 5 eys 3.33%, transient corneal edema in 0.67%, iris capture in 1.3%, there were no incidence of dislocation, slippage or endophthalmitis.

Conclusion
Yamane ISHF is a safe and effective technique for fixation of a three-piece IOL to the sclera with a good safety profile at 1 year of a followup
View More Presentations from this Session

This presentation is from the session "SPS-113 Cataract - Challenging Cases" from the 2020 ASCRS Virtual Annual Meeting held on May 16-17, 2020.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.